NCT06897345
Transversus Abdominis Plan Block Versus Rectus Sheath Block
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion date changed from estimate of Nov 1, 2025 to May 1, 2026
- Primary endpoint revised
- Completed without a posted recruiting period
- Secondary endpoints revised (2)
Notable Primary completion date changed from estimate of Nov 1, 2025 to May 1, 2026 Show 4 more changesShow less
- Study completion date changed from estimate of Dec 1, 2025 to Jun 1, 2026
- Eligibility criteria expanded, about 9 words
- Trial status: Not Yet Recruiting to Completed
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (2)
Arms and interventions
After administering 0.02 mg/kg midazolam for sedation to Group TAP patients, they will be placed in the supine position on both sides under sterile conditions using the high-frequency linear probe of the Esaote CA631 brand ultrasound, and the linear probe will be slid from the bilateral umblicus level to the midaxillary line, and when the internal and external oblique muscles are seen, the needle will be advanced from medial to lateral in an inplane manner, and the fascia between the internal oblique and transversus abdominis muscles will be reached, and after negative aspiration, 20 cc of 0.25% bubivacaine will be injected.
After administering 0.02 mg/kg midazolam for sedation, in the supine position, under sterile conditions, using the high-frequency linear probe of the Esaote CA631 brand ultrasound, 1 cm laterally over the umblicus, and after negative aspiration between the rectus muscle and the posterior rectus sheath, 20 cc of 0.25% bubivacaine will be injected (bilateral). 15 minutes after the block is applied, general anesthesia will be applied to the patients in both groups with 1 mcg/kg fentanyl, 2 mg/kg propofol, 0.6 mg/kg rocuronium intravenously and they will be orotracheal intubated. Intraoperative remifentanil needs will be recorded. Within the scope of multimodal analgesia, 1 g paracetamol will be administered to all patients 30 minutes before the end of the operation and 3 mg/kg sugammadex will be administered at the end of the operation and they will be extubated.
Procedures: transversus abdominis plane block, rectus sheat block
Sites
1 site in 1 country
- Sisli Hamidiye Etfal Training HospitalIstanbul, Turkey (Türkiye)